Investment House LLC Novartis Ag Transaction History

Investment House LLC

  • $1.81 Billion
  • Q4 2024

A detailed history of Investment House LLC transactions in Novartis Ag stock. As of the latest transaction made, Investment House LLC holds 82,304 shares of NVS stock, worth $8.77 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
82,304
Previous 82,379 0.09%
Holding current value
$8.77 Million
Previous $9.48 Million 15.47%
% of portfolio
0.44%
Previous 0.52%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
SELL
$96.78 - $117.18 $7,258 - $8,788
-75 Reduced 0.09%
82,304 $8.01 Million
Q3 2024

Nov 07, 2024
SELL
$106.13 - $120.89 $5,306 - $6,044
-50 Reduced 0.06%
82,379 $9.48 Million
Q2 2024

Jul 22, 2024
BUY
$92.57 - $107.37 $32,399 - $37,579
350 Added 0.43%
82,429 $8.78 Million
Q1 2024

May 02, 2024
BUY
$95.27 - $108.47 $100,033 - $113,893
1,050 Added 1.3%
82,079 $7.94 Million
Q4 2023

Feb 05, 2024
BUY
$92.27 - $101.54 $9,227 - $10,154
100 Added 0.12%
81,029 $8.18 Million
Q3 2023

Nov 09, 2023
SELL
$94.73 - $105.13 $150,241 - $166,736
-1,586 Reduced 1.92%
80,929 $8.24 Million
Q2 2023

Aug 08, 2023
SELL
$92.52 - $104.91 $159,134 - $180,445
-1,720 Reduced 2.04%
82,515 $8.33 Million
Q1 2023

May 09, 2023
SELL
$80.03 - $92.81 $41,775 - $48,446
-522 Reduced 0.62%
84,235 $7.75 Million
Q4 2022

Feb 07, 2023
SELL
$75.55 - $92.52 $265,180 - $324,745
-3,510 Reduced 3.98%
84,757 $7.69 Million
Q3 2022

Oct 31, 2022
BUY
$74.61 - $87.26 $189,733 - $221,902
2,543 Added 2.97%
88,267 $6.71 Million
Q2 2022

Aug 09, 2022
BUY
$80.52 - $93.75 $1.93 Million - $2.24 Million
23,921 Added 38.71%
85,724 $7.25 Million
Q1 2022

Apr 14, 2022
SELL
$80.11 - $90.62 $398,146 - $450,381
-4,970 Reduced 7.44%
61,803 $5.42 Million
Q4 2021

Feb 09, 2022
SELL
$79.7 - $88.13 $1.02 Million - $1.12 Million
-12,740 Reduced 16.02%
66,773 $5.84 Million
Q3 2021

Nov 12, 2021
SELL
$81.78 - $95.14 $563,300 - $655,324
-6,888 Reduced 7.97%
79,513 $6.5 Million
Q2 2021

Jul 20, 2021
BUY
$85.24 - $94.15 $124,024 - $136,988
1,455 Added 1.71%
86,401 $7.88 Million
Q1 2021

May 06, 2021
BUY
$83.5 - $98.47 $83,500 - $98,470
1,000 Added 1.19%
84,946 $7.26 Million
Q4 2020

Jan 13, 2021
BUY
$78.07 - $94.43 $49,964 - $60,435
640 Added 0.77%
83,946 $7.93 Million
Q3 2020

Nov 06, 2020
BUY
$82.14 - $91.0 $32,856 - $36,400
400 Added 0.48%
83,306 $7.24 Million
Q2 2020

Jul 13, 2020
BUY
$80.93 - $91.1 $285,925 - $321,856
3,533 Added 4.45%
82,906 $7.24 Million
Q1 2020

Apr 08, 2020
BUY
$70.67 - $99.01 $750,656 - $1.05 Million
10,622 Added 15.45%
79,373 $6.54 Million
Q4 2019

Feb 05, 2020
BUY
$84.35 - $95.37 $20,665 - $23,365
245 Added 0.36%
68,751 $6.51 Million
Q3 2019

Nov 12, 2019
BUY
$85.54 - $94.26 $208,717 - $229,994
2,440 Added 3.69%
68,506 $5.95 Million
Q2 2019

Aug 05, 2019
BUY
$75.4 - $92.8 $31,366 - $38,604
416 Added 0.63%
66,066 $6.03 Million
Q1 2019

May 03, 2019
BUY
$75.32 - $86.15 $11,297 - $12,922
150 Added 0.23%
65,650 $6.31 Million
Q4 2018

Feb 06, 2019
SELL
$73.66 - $82.02 $25,560 - $28,460
-347 Reduced 0.53%
65,500 $5.62 Million
Q3 2018

Oct 09, 2018
BUY
$66.94 - $77.43 $34,474 - $39,876
515 Added 0.79%
65,847 $5.67 Million
Q2 2018

Jul 10, 2018
SELL
$64.91 - $73.36 $17,266 - $19,513
-266 Reduced 0.41%
65,332 $4.94 Million
Q1 2018

May 08, 2018
SELL
$70.39 - $84.15 $33,787 - $40,392
-480 Reduced 0.73%
65,598 $5.3 Million
Q4 2017

Jan 31, 2018
BUY
$72.33 - $77.64 $14,466 - $15,528
200 Added 0.3%
66,078 $5.55 Million
Q3 2017

Oct 30, 2017
BUY
$74.14 - $77.27 $4.88 Million - $5.09 Million
65,878
65,878 $5.66 Million

Others Institutions Holding NVS

# of Institutions
1,468
Shares Held
134M
Call Options Held
1.4M
Put Options Held
1.61M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $229B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Investment House LLC Portfolio

Follow Investment House LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment House LLC, based on Form 13F filings with the SEC.

News

Stay updated on Investment House LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email